Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Japan post-marketing study of peficitinib use with methotrexate tapering in rheumatoid arthritis
jRCT1031240384Active, not recruiting
- Sponsor
- Astellas Pharma
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of peficitinib in rheumatoid arthritis (RA), sponsored by Astellas Pharma. Primary endpoint: Change in CDAI. Started Oct 2024; status: active, not recruiting.
02
Drugs
peficitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCT1031240384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031240384.